Berbari, P., Thibodeau, A., Germain, L. et al., 1999. Antiangiogenic effects of the oral administration of liquid cartilage extract in humans.J. Surg. Res. 87(1): 108–113.

Cohick, W. S., Clemmons, D. R., 1993. The insulin-like growth factors.Ann. Rev. Physiol. 55: 131–153.

Davis, P. F., He, Y., Furneaux, R. H. et al., 1997. Inhibition of angiogenesis by oral ingestion of powdered shark cartilage in a rat model.Microvasc Res. 54(2): 178–182.

Dupont, E., Savard, P. E., Jourdain, C., et al., 1998. Antiangiogenic properties of a novel shark cartilage extract: potential role in the treatment of psoriasis.J. Cutan. Med. Surg. 2(3): 146–152.

Fan, T. J., Wang, X. F., Shi, Z. P. et al., 2001. Co-inducing effect of basic fibroblast growth factor and insulin-like growth factor on cultured lymphocytes fromPenaeus chinensis.J. Oceanogrophy 23(5):180–184.

Fan, T. J., Wang, X. F., 2002. In vitro culture of embryonic cells from shrimpPenaeus chinensis.J. Exp. Marine Biol. Ecol. 267: 175–184.

Ingber, D. E., Folkman, J., 1989. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix.J. Cell Biol. 109: 317–330.

Iwamoto, M., 1988. Chondrocyte cytodifferentiation and calcification in a growth cartilage cell system.Osaka Daigaku Shigaku Zasshi 33(1):129–144.

Klaus, G., Meinhold-Heerlein, R., Milde, P., et al., 1991. Effect of vitamin D on growth and cartilage cell proliferation in vitro.Pediatr Nephrol. 5(4):461–466.

Klaus, G., Weber, L., Rodriguez, J. et al., 1998. Interaction of IGF-I and 1 alpha, 25(OH)2D3 on receptor expression and growth stimulation in rat growth plate chondrocytes. Kidney Int,53(5): 1152–1161.

Lavietes, B. B., 1971. Kinetics of matrix synthesis in cartilage cell cultures.Exp. Cell Res. 68(1): 43–48.

Mathews, J., 1993. Media feeds frenzy over shark cartilage as cancer treatment.J. Natl. Cancer Inst. 85 (15): 1190–1191.

McGuire, T. R., Kazakoff, P. W., Hoie, E. B. et al., 1996. Antiproliferative activity of shark cartilage with and without tumor necrosis factor-alpha in human umbilical vein endothelium.Pharmacotherapy 16(2): 237–244.

Moses, M. A., Sudhalter, J., Langer, R., 1990. Identification of an inhibitor of neovascularization from cartilage.Science 248(4961): 1408–1410.

Moses, M. A., 1993. A cartilage-derived inhibitor of neovascularization and metalloproteinases.Clin. Exp. Rheumatol suppl. 8: S67–9.

Nagai, H., Tsukuda, R., Yamasaki, H. et al., 1999. Systemic injection of FGF-2 stimulates endocortical bone modelling in SAMP6, a murine model of low turnover osteopenia.J. Vet. Med. Sci. 61(8): 869–875.

Oikawa, T., Ashino-Fuse, H., Shimamura, M. et al., 1990. A novel angiogenic inhibitor derived from Japanese shark cartilage (I). Extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis.Cancer Lett. 51(3): 181–186.

Sheu, J. R., Fu, C. C., Tsai, M. L. et al., 1998. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.Anticancer Res. 18(6A): 4435–4441.

Somjen, D., Kaye, A. M., Binderman, I., 1984. 24R, 25-dihydroxyvitamin D stimulates creatine kinase BB activity in chick cartilage cells in culture.FEBS Lett. 167(2): 281–284.

Verbruggen, G., Malfait, A. M., Almqvist, K. F. et al., 1993. Development of immortalized human articular cartilage cell lines.Agents Actions Suppl. 39: 267–272.

Weiss, A., von der Mark, K., Silbermann, M., 1986. A tissue culture system supporting cartilage cell differentiation extracellular mineralization, and subsequent bone formation, using mouse condylar progenitor cells.Cell Differ. 19(2): 103–113.

Yu, Z. J., Cai, P., Lu, J. B., 1997. Clinical studies of “Shark cartilage extract” capsules in tumor therapy.Chinese Marine Drugs 1: 12–14.